BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29546333)

  • 1. Recent and Rapid Transmission of HIV Among People Who Inject Drugs in Scotland Revealed Through Phylogenetic Analysis.
    Ragonnet-Cronin M; Jackson C; Bradley-Stewart A; Aitken C; McAuley A; Palmateer N; Gunson R; Goldberg D; Milosevic C; Leigh Brown AJ
    J Infect Dis; 2018 May; 217(12):1875-1882. PubMed ID: 29546333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis.
    McAuley A; Palmateer NE; Goldberg DJ; Trayner KMA; Shepherd SJ; Gunson RN; Metcalfe R; Milosevic C; Taylor A; Munro A; Hutchinson SJ
    Lancet HIV; 2019 May; 6(5):e315-e324. PubMed ID: 30981674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the scale-up of HIV testing among people who inject drugs in Scotland in the context of an ongoing HIV outbreak.
    Trayner KMA; Palmateer NE; McAuley A; Metcalfe R; Goldberg DJ; Peters E; Craik J; Gunson RN; Thain D; Carter D; Hutchinson SJ
    Int J Drug Policy; 2021 Oct; 96():103304. PubMed ID: 34325970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injection of cocaine is associated with a recent HIV outbreak in people who inject drugs in Luxembourg.
    Arendt V; Guillorit L; Origer A; Sauvageot N; Vaillant M; Fischer A; Goedertz H; François JH; Alexiev I; Staub T; Seguin-Devaux C
    PLoS One; 2019; 14(5):e0215570. PubMed ID: 31095576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed Molecular Surveillance of the HIV-1 Outbreak Among People who Inject Drugs (PWID) in Athens During a Period of Four Years.
    Kostaki E; Magiorkinis G; Psichogiou M; Flampouris A; Iliopoulos P; Papachristou E; Daikos GL; Bonovas S; Otelea D; Friedman SR; Hatzakis A; Paraskevis D
    Curr HIV Res; 2017; 15(6):396-404. PubMed ID: 29165088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular investigation of HIV-1 cross-group transmissions during an outbreak among people who inject drugs (2011-2014) in Athens, Greece.
    Paraskevis D; Nikolopoulos GK; Sypsa V; Psichogiou M; Pantavou K; Kostaki E; Karamitros T; Paraskeva D; Schneider J; Malliori M; Friedman SR; Des Jarlais DC; Daikos GL; Hatzakis A
    Infect Genet Evol; 2018 Aug; 62():11-16. PubMed ID: 29653216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of HIV among people who inject drugs after the HIV-outbreak in Athens, Greece: Evidence for a 'slow burn' outbreak.
    Kostaki EG; Roussos S; Kefala AM; Limnaios S; Psichogiou M; Papachristou E; Nikolopoulos G; Flountzi E; Friedman SR; Lagiou P; Hatzakis A; Sypsa V; Magiorkinis G; Beloukas A; Paraskevis D
    Infect Genet Evol; 2024 Jul; 121():105597. PubMed ID: 38663466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatiotemporal Reconstruction of the Introduction of Hepatitis C Virus into Scotland and Its Subsequent Regional Transmission.
    McNaughton AL; Cameron ID; Wignall-Fleming EB; Biek R; McLauchlan J; Gunson RN; Templeton K; Tan HM; Leitch EC
    J Virol; 2015 Nov; 89(22):11223-32. PubMed ID: 26311892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of HIV and other infections and injection behaviours among people who inject drugs in Addis Ababa, Ethiopia.
    Demissie M; Johnston LG; Muleta M; Desyebelew D; Belete W; G/Egxiabehre A; Gezahegn N; Kassa D; Aseffa Y
    Afr J AIDS Res; 2018 Sep; 17(3):259-264. PubMed ID: 30319040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
    Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A
    Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects.
    Vasylyeva TI; Friedman SR; Lourenco J; Gupta S; Hatzakis A; Pybus OG; Katzourakis A; Smyrnov P; Karamitros T; Paraskevis D; Magiorkinis G
    AIDS; 2016 Nov; 30(18):2885-2890. PubMed ID: 27824626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. People who inject drugs in Bangladesh - The untold burden!
    Khan SI; Reza MM; Crowe SM; Rahman M; Hellard M; Sarker MS; Chowdhury EI; Rana AKMM; Sacks-Davis R; Banu S; Ross AG
    Int J Infect Dis; 2019 Jun; 83():109-115. PubMed ID: 30928433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance.
    Rosińska M; Sierosławski J; Wiessing L
    BMC Infect Dis; 2015 Feb; 15():83. PubMed ID: 25879904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 phylodynamic analysis among people who inject drugs in Pakistan correlates with trends in illicit opioid trade.
    Cholette F; Joy J; Pelcat Y; Thompson LH; Pilon R; Ho J; Capina R; Archibald C; Blanchard JF; Emmanuel F; Reza T; Dar N; Harrigan R; Kim J; Sandstrom P
    PLoS One; 2020; 15(8):e0237560. PubMed ID: 32857765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV- and hepatitis C-related risk behaviors among people who inject drugs in Uganda: implications for policy and programming.
    Baluku M; Wamala T; Muhangi D
    Harm Reduct J; 2019 Sep; 16(1):56. PubMed ID: 31481086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
    Solomon SS; McFall AM; Lucas GM; Srikrishnan AK; Kumar MS; Anand S; Quinn TC; Celentano DD; Mehta SH
    PLoS Med; 2017 Nov; 14(11):e1002460. PubMed ID: 29182638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hepatitis C outbreak preceded the HIV outbreak among persons who inject drugs in Athens, Greece: Insights from a mathematical modelling study.
    Gountas I; Sypsa V; Papatheodoridis G; Paraskevis D; Kalamitsis G; Anagnostou O; Antaraki A; Fotiou A; Hatzakis A
    J Viral Hepat; 2019 Nov; 26(11):1311-1317. PubMed ID: 31322302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
    Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
    J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
    Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
    Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.